ASCO: Bladder Sparing Studied in Muscle-Invasive Bladder Cancer
Transurethral resection then gemcitabine, cisplatin, plus nivolumab with intact bladder in selected patients studied in phase 2 trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.